Join us for the ACC Delaware Chapter Meeting: ACC by the Sea for engaging live education sessions from local, regional, and national experts with Q&A real-time. The educational meeting includes topics of cardio obstetrics, lipids, amyloid, etc., and a chapter update from our Governor Dr. Vinay Hosmane. Participation in this event will earn CME/CNE/and MOC. We look forward to seeing you (IN-PERSON) September 12 - 13, 2025!

For more Information and Register: Delaware ACC By the Sea: 2025 Chapter Meeting

Delaware Chapter of the American College of Cardiology


Our purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments.

ACC Live Courses

For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings

RSS Latest in Cardiology from ACC.org

  • Is Occupational Physical Work Exposure a Risk Factor For ATTRwt-CM?
    In a registry-based study, an association was found between transthyretin wild-type amyloid cardiomyopathy (ATTRwt-CM) and occupational upper-body mechanical stress, along with a greater burden of orthopedic and cardiovascular comorbidities including increased cardiovascular mortality among patients with ATTRwt-CM. The hypothesis-generating findings were published Feb. 24 in JACC: Advances.
  • Is Progression of Myocardial Fibrosis a Risk Indicator in HCM?
    Myocardial fibrosis increased over time in patients with hypertrophic cardiomyopathy (HCM), as assessed by late gadolinium enhancement (LGE) on follow-up cardiac MR, suggesting a higher risk for adverse outcomes, including all-cause mortality, hospitalization and stroke, according to research published Feb. 20 in JACC: Cardiovascular Imaging.
  • Nonobstructive HCM Treatment: Differential Effect of Bisoprolol vs. Verapamil
    Bisoprolol but not verapamil reduced peak oxygen consumption (pVO2) in patients with nonobstructive hypertrophic cardiomyopathy (HCM), according to research published March 3 in JACC.
  • Your ACC Urges Reclassification of APRN, PA Degrees as Professional
    The U.S. Department of Education has categorized APRN and PA clinicians as "graduate" students rather than "professional" students under the One Big Beautiful Bill Act, lowering their federal loan limits.
  • Extended DAPT in Multivessel CAD: Less Ischemia Without a Major Bleeding Penalty
    The DAPT-MVD (Dual Antiplatelet Therapy in Patients With Coronary Multi-Vessel Disease) trial was a multicenter, randomized, open-label study in China designed to assess whether extending dual antiplatelet therapy (DAPT) beyond 12 months provides additional benefit for patients with multivessel coronary artery disease (CAD)...